Artal Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-405,000
| Closed | -$3.39M | – | 105 |
|
|
2019
Q4 | $3.39M | Hold |
405,000
| – | – | 0.13% | 73 |
|
|
2019
Q3 | $3.67M | Hold |
405,000
| – | – | 0.15% | 71 |
|
|
2019
Q2 | $4.36M | Buy |
405,000
+5,000
| +1% | +$53.9K | 0.18% | 71 |
|
|
2019
Q1 | $3.82M | Hold |
400,000
| – | – | 0.16% | 70 |
|
|
2018
Q4 | $4.59M | Buy |
400,000
+100,000
| +33% | +$1.15M | 0.17% | 45 |
|
|
2018
Q3 | $5.09M | Buy |
300,000
+100,000
| +50% | +$1.7M | 0.13% | 54 |
|
|
2018
Q2 | $2.84M | Buy |
200,000
+50,000
| +33% | +$710K | 0.06% | 64 |
|
|
2018
Q1 | $2.85M | Buy |
+150,000
| New | +$2.85M | 0.04% | 61 |
|